Li Wen, He Songwei, Zhou Yuye, Li Yuan, Hao Jianbang, Zhou Xingru, Wang Feng, Zhang Yang, Huang Zhenhua, Li Zhiyuan, Loh Horace H, Law Ping-Yee, Zheng Hui
CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences.
College of Pharmacy, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Jinan University.
Biol Psychiatry. 2014 Nov 15;76(10):775-84. doi: 10.1016/j.biopsych.2014.05.013. Epub 2014 Jun 2.
The activity of neurogenic differentiation 1 (Neurod1) decreases after morphine administration, which leads to impairments of the stability of dendritic spines in primary hippocampal neurons, adult neurogenesis in mouse hippocampi, and drug-associated contextual memory. The current study examined whether Neurod1 could affect the development of opioid tolerance.
Lentivirus encoding Neurod1, microRNA-190 (miR-190), or short hairpin RNA against Neurod1 was injected into mouse hippocampi separately or combined (more than eight mice for each treatment) to modulate NeuroD1 activity. The antinociceptive median effective dose values of morphine and fentanyl were determined with tail-flick assay and used to calculate development of tolerance. Contextual learning and memory were assayed using the Morris water maze.
Decrease in NeuroD1 activity increased the initial antinociceptive median effective dose values of both morphine and fentanyl, which was reversed by restoring NeuroD1 activity. In contrast, decrease in NeuroD1 activity inhibited development of tolerance in a time-dependent manner, paralleling its effects on the acquisition and extinction of contextual memory. In addition, only development of tolerance, but not antinociceptive median effective dose values, was modulated by the expression of miR-190 and Neurod1 driven by Nestin promoter.
Neurod1 regulates the developments of opioid tolerance via a time-dependent pathway through contextual learning and a short-response pathway through antinociception.
给予吗啡后神经源性分化因子1(Neurod1)的活性降低,这导致原代海马神经元树突棘稳定性受损、小鼠海马体中的成年神经发生以及与药物相关的情境记忆受损。本研究检测了Neurod1是否会影响阿片类药物耐受性的发展。
将编码Neurod1、微小RNA-190(miR-190)或针对Neurod1的短发夹RNA的慢病毒分别或联合注射到小鼠海马体中(每种处理超过八只小鼠)以调节NeuroD1活性。用甩尾试验测定吗啡和芬太尼的抗伤害感受半数有效剂量值,并用于计算耐受性的发展。使用莫里斯水迷宫检测情境学习和记忆。
NeuroD1活性降低增加了吗啡和芬太尼的初始抗伤害感受半数有效剂量值,恢复NeuroD1活性可使其逆转。相反,NeuroD1活性降低以时间依赖性方式抑制耐受性的发展,这与其对情境记忆的获得和消退的影响平行。此外,只有耐受性的发展,而不是抗伤害感受半数有效剂量值,受到由巢蛋白启动子驱动的miR-190和Neurod1表达的调节。
Neurod1通过情境学习的时间依赖性途径和抗伤害感受的短反应途径调节阿片类药物耐受性的发展。